A recent analysis found a much higher major infection rate in patients receiving a liberalized diet vs a neutropenic diet, ...
The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in ...
For adults with acute leukemia (AL) undergoing hematopoietic stem cell transplant (HSCT) or induction chemotherapy, a ...
Pirtobrutinib significantly improved progression-free survival in untreated CLL/SLL patients compared to standard chemoimmunotherapy in the BRUIN CLL-313 trial. Early trends suggest potential overall ...
5-year follow-up from SEQUOIA study demonstrated treatment with BRUKINSA reduced the risk of progression or death by 71% compared to bendamustine-rituximab in patients with treatment-naïve CLL, ...